MedPath

Comparing effects of diaphragm muscle release technique and chest mobilization on breathlessness and expansion of chest in patients with obstructive lung disease

Not yet recruiting
Conditions
Other specified respiratory disorders,
Registration Number
CTRI/2025/03/083111
Lead Sponsor
Himanshika Gautam
Brief Summary

Chronic obstructive pulmonary disease (COPD) is defined by ongoing and typically worsening restrictions in airflow. The primary risk factor is smoking, but the condition is also linked to environmental pollution, workplace exposures, genetic changes, and the effects of aging. It is a diverse lung condition characterized by chronic respiratory symptoms. It results from problems with the air sacs and air passages. It ultimately results in a disruption of airflow that is persistent occasionally gets worsened. However, early detection and treatment of COPD, in addition to lifestyle modifications like discontinuing smoking and exercising regularly, improves the quality of life for those who are affected and minimizes the disease’s progression. This is a diverse condition that exhibits significant differences in how it progresses. It leads to sudden worsening of respiratory symptoms that is linked to varying levels of physiological decline. The MDRT and CMT are effective clinical approaches for managing patients with COPD. They aid in alleviating symptoms such as dyspnea and enhancing chest excursion. Additionally, these techniques have proven beneficial for other conditions like asthma and Neuromuscular Disorders (NMD), positively impacting cardiorespiratory and physiological functions. There is a notable gap in comprehensive evaluations of their effectiveness. This lack of published literature and rigorous assessment makes it challenging to determine how well the techniques work compared to other interventions or therapies. More research is needed to establish clear evidence of their benefits and to understand role in the management of respiratory conditions. There is a need for research to compare the efficacy of both techniques. Identifying which method is more effective could allow healthcare providers to incorporate it alongside standard exercises for these patients. This integration aims to improve their quality of life, shorten hospital stays, and boost lung capacity for those dealing with respiratory challenges.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Diagnosed cases of COPD using Gold Standard method.
  • Both Male and Female.
  • Age group between 40 years to 70 years.
  • Patients with an exacerbation of COPD.
  • Value of Pulmonary Function Test below normal value.
  • Patients with symptoms of shortness of breath.
Exclusion Criteria
  • Patients with unstable vitals 2.
  • Patients with any active lung infections or any other respiratory conditions such as pneumonia, lung carcinoma 3.
  • Patients with uncontrolled Diabetes Mellites 4.
  • Patients of progressive diseases seriously influencing waling ability, amputation, muscular dystrophies, paralysis 5.
  • Patients with multidrug resistance COPD 6.
  • Patients with psychological disorders 7.
  • Patients who are non – cooperative.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Single breath count 2. Chest excursion 3. PFT 4. COPD assessment testat baseline and after one week
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maharishi Markandeshwar University

🇮🇳

Solan, HIMACHAL PRADESH, India

Maharishi Markandeshwar University
🇮🇳Solan, HIMACHAL PRADESH, India
Himanshika Gautam
Principal investigator
6230226218
ghimanshika@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.